Chief Strategy Officer, Venebio Group, LLC

Maciek serves as Chief Strategy Officer for Venebio Group, LLC. He is a physician-scientist and educator with particular emphasis on cardiovascular and cardiometabolic health.  Prior to his clinical work, he developed an algorithm to predict the behavior of thermonuclear fusion plasmas.

In 1996, Maciek established the Bioinformatics Center at the Clemson University Genomics Institute, serving as Director of Bioinformatics. In 1998, he founded INCOGEN, a biotechnology company focused on the development of technological platforms and cancer biomarker research. There, he served as CEO until joining Health Diagnostic Laboratory as Vice President of Clinical Affairs, before joining Venebio as Chief Strategy Officer.

Over the last two decades, Maciek played leading roles in technology integration efforts and has been actively involved in technology policy development at national and statewide levels, serving on the Governor’s Technology Transition Policy Committee in Virginia and as the former Chairman of the Virginia Biotechnology Association.

He founded the Viral Initiative to Rebuild U.S. Health (VIRUS Health), a not-for- profit organization that promotes healthy lifestyle habits.  He received recognition for his efforts as a researcher and clinician, including being chosen by Genome Technology Magazine as one of the most influential people in the field of genomics and being voted Top 40 Under 40 by Richmond’s Style Weekly.

Maciek has published over 30 peer-reviewed articles and book chapters, as well as given hundreds of lectures world-wide in physics, bioinformatics, and clinical research, and has attracted almost $20 million in federal and state research funding. Maciek earned a PhD in computational plasma physics from the College of William and Mary and an MD from the Medical College of Virginia.